No Data
No Data
BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90
Insmed's Strategic Growth and Market Potential Drive Buy Recommendation
Goldman's Hedge Fund VIP List: AMZN, VST, CRM, BABA, and More
Top Gap Ups and Downs on Tuesday: SMCI, WMT, BBY and More
Express News | Insmed Inc - No Termination Penalties for Terminating Agreement
Express News | Insmed Inc - Terminates Sales Agreement With Leerink Partners LLC Effective Immediately
No Data
No Data